New York-based DarioHealth Corp. operates as a digital therapeutics company across several countries including the United States, Canada, the European Union, Australia, and New Zealand. The company provides a comprehensive portfolio of digital health solutions that address various health needs, such as diabetes, hypertension, weight management, musculoskeletal (MSK) conditions, and behavioral health. Its offerings include Dario Evolve, Dario Move, Dario Elevate, Dario One, DarioEngage platform, Dario blood glucose monitoring system, smart glucose meters, Bluetooth connected blood pressure cuff, digital scales, biofeedback sensor devices, and Dario smart diabetes management solutions. These solutions are designed to offer live clinical coaching, automated journeys, hardware, lifestyle coaching, and evidence-based care. The company previously operated under the name LabStyle Innovations Corp. but rebranded as DarioHealth Corp. in July 2016.
DarioHealth's ticker is DRIO
The company's shares trade on the NASDAQ stock exchange
They are based in New York City, New York
There are 51-200 employees working at DarioHealth
It is dariohealth.com
DarioHealth is in the Healthcare sector
DarioHealth is in the Diagnostic Substances industry
The following five companies are DarioHealth's industry peers: